Grant: Discovery Grants Program - Individual
Université de Montréal
$40,000.00
Regulation of neutrophil antimicrobial defense through the pleiotropic receptor FPR2/ALX
FY 2024-25
Summary
Background and Rationale: Neutrophil granulocytes play crucial role in fighting invading pathogens by phagocytosis, release of extracellular traps (NETs) or liberation of free radicals and proteolytic proteins. Functional silencing and removal of neutrophils are essential for the timely resolution of infection. Formyl peptide receptors (FPRs), and FPR2/ALX (FPR2 and lipoxin receptor) in particular, bind diverse ligands, including inflammatory mediators, (e.g. N-formylated peptides and serum amyloid A) and pro-resolving lipid mediators (e.g. lipoxin A4 and resolvin D1), which convey opposing biological responses. We hypothesize that pro-inflammatory FPR2/ALX ligands would impair phagocytosis of bacteria, suppress phagocytosis-induced cell death, and trigger NET formation, whereas pro-resolving FPR2/ALX ligands could counter these actions and consequently enhance clearance of bacteria and facilitate resolution of infection. Our overarching goal is to further explore the versatility of intracellular signalling pathways that govern neutrophil functions.
Aim 1. To investigate the molecular basis of FPR2/ALX regulation of phagocytosis and bacterial killing by human neutrophils. We will study the effects of inflammatory and pro-resolving FPR2/ALX agonists on degranulation, complement receptors, phagocytosis, apoptosis and bacterial killing. We will explore intracellular signalling pathways using phosphokinase arrays, phosphatase screens, immunoblotting and pharmacological inhibitors. To confirm dual-specificity phosphatases (DUSP) as "stop signals", we will generate transient DUSP knockdown in HL-60 cells (as a model of neutrophils).
Aim 2. To identify the molecular switches activated by various FPR2/ALX ligands, which govern neutrophil phagocytosis versus NET formation. We will monitor NET release by human neutrophils challenged with various FPR2/ALX ligands and define downstream signaling pathways using phosphokinase arrays and selective pharmacological inhibitors of various kinases, degranulation and peptidyl-arginine deiminase 4.
Aim 3. To assess the impact of modulating neutrophil function by FPR2/ALX ligands on the outcome of bacterial infection in vivo. We will study the effects of N-formyl peptides on bacterial clearance, neutrophil apoptosis, efferocytosis, NET formation and the resolution of lung inflammation in male and female mice. We will assess whether these actions can be countered by treatment with 15-epi-LXA or 17-epi-resolvin D1.
Significance: We anticipate that answering the fundamental questions outlined above will advance our understanding how FPR2/ALX integrates opposing cues to regulate antimicrobial defense, and can be harnessed to develop FPR2/ALX-centered strategies to restore or enhance neutrophil functions to dampen inflammation and favour reparative processes. The project will also provide excellent multidisciplinary training opportunities for HQPs in the fields of innate immunity and resolution biology.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2023-03617
Name nom
Filep, Janos
Department département
Pathologie et biologie cellulaire - Pathologie et biologie cellulaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Regulation of neutrophil antimicrobial defense through the pleiotropic receptor FPR2/ALX
Keywords
neutrophil granulocytes; phagocytosis; net formation; formyl peptide receptors; bacterial killing; pro-resolving lipid mediators; intracellular signaling; inflammation; resolution of inflammation
Application summary
Background and Rationale: Neutrophil granulocytes play crucial role in fighting invading pathogens by phagocytosis, release of extracellular traps (NETs) or liberation of free radicals and proteolytic proteins. Functional silencing and removal of neutrophils are essential for the timely resolution of infection. Formyl peptide receptors (FPRs), and FPR2/ALX (FPR2 and lipoxin receptor) in particular, bind diverse ligands, including inflammatory mediators, (e.g. N-formylated peptides and serum amyloid A) and pro-resolving lipid mediators (e.g. lipoxin A4 and resolvin D1), which convey opposing biological responses. We hypothesize that pro-inflammatory FPR2/ALX ligands would impair phagocytosis of bacteria, suppress phagocytosis-induced cell death, and trigger NET formation, whereas pro-resolving FPR2/ALX ligands could counter these actions and consequently enhance clearance of bacteria and facilitate resolution of infection. Our overarching goal is to further explore the versatility of intracellular signalling pathways that govern neutrophil functions.
Aim 1. To investigate the molecular basis of FPR2/ALX regulation of phagocytosis and bacterial killing by human neutrophils. We will study the effects of inflammatory and pro-resolving FPR2/ALX agonists on degranulation, complement receptors, phagocytosis, apoptosis and bacterial killing. We will explore intracellular signalling pathways using phosphokinase arrays, phosphatase screens, immunoblotting and pharmacological inhibitors. To confirm dual-specificity phosphatases (DUSP) as "stop signals", we will generate transient DUSP knockdown in HL-60 cells (as a model of neutrophils).
Aim 2. To identify the molecular switches activated by various FPR2/ALX ligands, which govern neutrophil phagocytosis versus NET formation. We will monitor NET release by human neutrophils challenged with various FPR2/ALX ligands and define downstream signaling pathways using phosphokinase arrays and selective pharmacological inhibitors of various kinases, degranulation and peptidyl-arginine deiminase 4.
Aim 3. To assess the impact of modulating neutrophil function by FPR2/ALX ligands on the outcome of bacterial infection in vivo. We will study the effects of N-formyl peptides on bacterial clearance, neutrophil apoptosis, efferocytosis, NET formation and the resolution of lung inflammation in male and female mice. We will assess whether these actions can be countered by treatment with 15-epi-LXA or 17-epi-resolvin D1.
Significance: We anticipate that answering the fundamental questions outlined above will advance our understanding how FPR2/ALX integrates opposing cues to regulate antimicrobial defense, and can be harnessed to develop FPR2/ALX-centered strategies to restore or enhance neutrophil functions to dampen inflammation and favour reparative processes. The project will also provide excellent multidisciplinary training opportunities for HQPs in the fields of innate immunity and resolution biology.